CENTRAL & EASTERN EUROPE INVESTMENT OPPORTUNITIES IN PHARMACEUTICALS: RISK/REWARD ANALYSIS

| January 18, 2018

article image
Central & Eastern European markets are not considered amongst the most attractive globally for companies looking to launch innovative pharmaceuticals. The Czech Republic, which ranks first in Central & Eastern Europe, is ranked 22nd globally, whilst the region's second-ranked country, Poland is ranked 24th. Scoring in the Innovative Pharmaceuticals RRI favours larger markets with greater sales potential for multinationals. Indeed, neither market can compete with the high per-capita expenditure or absolute market size of the top global markets.

Spotlight

Tickit Health

Tickit® is a patient data collection and analytics engagement platform with a proprietary design approach awarded for its inclusive methodologies. Proven to yield better data for healthcare teams worldwide, Tickit® makes it easy to collect and understand patient data. Tickit Health is on a mission to reduce the rising cost of care by empowering providers with patient-reported data, and we collaborate with clients worldwide to build interactive health questionnaires that enable healthcare organizations to identify at-risk patients. With real-time data collection, insightful analytics, and streamlined operational reporting, Tickit Health’s patient engagement software efficiently improves health outcomes across the care continuum.

OTHER ARTICLES

What to Watch in 2020: Non-Specialty Drugs

Article | March 1, 2020

Pharmaceutical manufacturers are constantly working to develop new and improved medications. Join us as we explore the non-specialty drugs you should be watching in 2020. If you missed last week’s article about the most important upcoming specialty drugs, be sure to check it out here. Approximately 40 new medications are approved by the Food and Drug Administration (FDA) every year.1 (Please note: If you’re curious about what it takes to develop a drug and bring it to market, check out our previous article). Why should you care about these new medications? Because they can affect both your organization’s pharmacy spend and your members’ cost share. For non-specialty drugs, we will focus on medications that may come to market this year, including ones that are currently being reviewed by the FDA, or that are in the last clinical trial (Phase III) stage.

Read More

Clinical Development Risks and Issues in a COVID-19 World

Article | March 20, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

A pharma outsourcing mission

Article | August 18, 2021

In a way, getting through the initial stages of a complex pharmaceutical project that is being outsourced to a contract development and manufacturing organization is like getting a rocket off the ground. Many drug developers express frustration with the time it often takes during the initial stages of working with a CDMO — from the time they first reach out to a CDMO for help until they receive a proposal. Some have described it as months of silence from when they send a request for proposal (RFP) until they have a proposal in hand. The initial stages of a relationship between drug sponsor and CDMO often do not get the attention it deserves, and valuable time is lost, delaying projects and delaying delivery of therapeutics to patients. The quick scheduling of the ACT meeting with the right attendees can deliver immediate answers to key questions needed by the drug sponsor for effective planning and can help propel projects to a successful launch.

Read More

What are the advantages of PCD Pharma Company?

Article | February 17, 2020

PCD Pharma stands for propaganda distribution. A PCD company gives brand name and support to its franchises. They also provide distribution rights and monopoly rights within a particular region. If a person wants to establish their business, it is a must for them to know the pros and cons of the business to make a sound decision. Needless to mention that PCD company has a lot to contribute in the medical filed. Worldwide in a medical field, A PCD Pharma Company is playing an essential and crucial role in the rapid growth. The pharma industry is progressing t a fast pace. The company uses the latest technologies for each brand which ensures the safety of products and accepts the responsibility of human health & life by providing better outcomes. To have a drug license number and company registration, the cost to establish the company is quite cost-effective that is15000-20000rs. So this gives people a brilliant opportunity to have their unit without digging a big hole in their bank balance. Indian produces exquisite quality products, which make pharma companies a considerable success.

Read More

Spotlight

Tickit Health

Tickit® is a patient data collection and analytics engagement platform with a proprietary design approach awarded for its inclusive methodologies. Proven to yield better data for healthcare teams worldwide, Tickit® makes it easy to collect and understand patient data. Tickit Health is on a mission to reduce the rising cost of care by empowering providers with patient-reported data, and we collaborate with clients worldwide to build interactive health questionnaires that enable healthcare organizations to identify at-risk patients. With real-time data collection, insightful analytics, and streamlined operational reporting, Tickit Health’s patient engagement software efficiently improves health outcomes across the care continuum.

Events